milrinone and thromboxane a2

milrinone has been researched along with thromboxane a2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gill, J; Jeremy, JY; Mikhailidis, D1
Barradas, MA; Jagroop, A; Jeremy, JY; Mikhailidis, DP; O'Donoghue, S1
Levy, JH; Salmenperä, M1
Ahmad, A; Floten, S; Furnary, A; Gately, H; He, GW; Starr, A; Swanson, J; Wood, J; Yang, CO1
He, GW; Yang, CQ1

Other Studies

5 other study(ies) available for milrinone and thromboxane a2

ArticleYear
Effect of milrinone on thromboxane A2 synthesis, cAMP phosphodiesterase and 45Ca2+ uptake by human platelets.
    European journal of pharmacology, 1993, Mar-15, Volume: 245, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Calcium; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Milrinone; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridones; Thromboxane A2

1993
Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
    Thrombosis research, 1993, Aug-01, Volume: 71, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Blood Platelets; Calcimycin; Cells, Cultured; Humans; Indomethacin; Milrinone; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Serotonin; Thromboxane A2

1993
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
    Anesthesia and analgesia, 1996, Volume: 82, Issue:5

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents

1996
Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents

1996
Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Arteries; Cardiovascular Agents; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents

1996